ZANDRA RIVERA: Open Payments
NPI 1134209802 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,671 in 28 payments from 17 companies in 2025. Trend: 2023 $1,209 · 2024 $1,283 · 2025 $2,671
Food & beverage: $2,617Education: $50Speaker / faculty: $4
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $468 |
| Daiichi Sankyo Inc. | 4 | $428 |
| SANOFI-AVENTIS U.S. LLC | 2 | $235 |
| Syndax Pharmaceuticals, Inc. | 2 | $176 |
| JAZZ PHARMACEUTICALS INC. | 1 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $137 |
| AstraZeneca Pharmaceuticals LP | 1 | $132 |
| Eisai Inc. | 1 | $124 |
| GENZYME CORPORATION | 1 | $119 |
| GlaxoSmithKline, LLC. | 1 | $119 |
Products named: DATROWAY, REZUROCK, Jakafi, Enhertu, ZIIHERA, Nubeqa, Vanflyta, Monjuvi.
Industry payments across TX — which companies pay providers there.
